Table 3.

Survival Analysis of Different Risk Groups and Combination Analysis

Variables	OS		OS*
	Crude HR (95% CI)	Crude P	Adjusted HR (95% CI)	Adjusted P
Low-risk group	1		1
High-risk group	1.529 (1.242–1.882)	<0.001	1.400 (1.078–1.819)	0.012
High ALI and low-risk group	1		1
High ALI and High-risk group	2.238 (1.743–2.874)	<0.001	2.260 (1.666–3.065)	<0.001
Low ALI and Low-risk group	1.524 (1.035–2.245)	0.033	1.685 (1.105–2.570)	0.015
Low ALI and High-risk group	2.973 (2.242–3.943)	<0.001	3.095 (2.085–4.592)	<0.001

Notes: *Adjusted for age, sex and TNM stage; adjusted for age, sex, TNM stage, radical resection, postoperative chemoradiotherapy, ECOG PS, KPS, BMI, family history of cancer, tea consumption, alcohol consumption, smoking, diabetes, hypertension, coronary heart disease, AST, ALT, hemoglobin, serum total protein, serum albumin, WBC, lymphocytes, neutrophils, platelet, 30-day mortality, PGSGA, nutritional intervention.

Abbreviations: OS, overall survival; HR, hazards ratio; CI, confidence interval; BMI, body mass index; ECOG PS, Eastern Cooperative Oncology Group Performance Status; KPS, Karnofsky Performance Status; AST, aspartate aminotransferase; ALT, alanine transaminase; WBC, white blood cells; ALI, advanced lung cancer inflammation index; NLR, neutrophil–lymphocyte ratio; PNI, prognostic nutritional index; SII, systemic immune-inflammation index; PLR, platelet–lymphocyte ratio; PGSGA, Patient-Generated Subjective Global Assessment.